Assured Pharmacy Inc (APHY) Financial Statements (2025 and earlier)

Company Profile

Business Address 5600 TENNYSON PARKWAY
PLANO, TX 75024
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2525737912
Cash and cash equivalent2525737912
Receivables30144324264408786
Disposal group, including discontinued operation08426  
Prepaid expense and other current assets141
Other undisclosed current assets479566499650426407
Total current assets:5349758309468431,346
Noncurrent Assets
Property, plant and equipment768178779391
Intangible assets, net (including goodwill)   698
Goodwill      698
Assets of disposal group, including discontinued operation136137141141  
Other undisclosed noncurrent assets    14184195
Total noncurrent assets:212219219232277984
TOTAL ASSETS:7461,1931,0491,1781,1212,330
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,8081,5471,6432,3352,3241,782
Accrued liabilities   39   
Other undisclosed accounts payable and accrued liabilities1,8081,5471,6032,3352,3241,782
Debt3,8673,8654264,0394924,065
Due to related parties240240 877488 
Other undisclosed current liabilities4925055083,0342,7662,392
Total current liabilities:6,4086,1562,57710,2866,0708,238
Noncurrent Liabilities
Long-term debt and lease obligation     3,547 
Long-term debt, excluding current maturities     3,547 
Liabilities, other than long-term debt912927789  453
Due to related parties727677477  453
Derivative instruments and hedges, liabilities 185250312   
Other undisclosed noncurrent liabilities1,8712,0075,633289412871
Total noncurrent liabilities:2,7832,9346,4222893,9591,324
Total liabilities:9,1919,0908,99910,57510,0299,563
Equity
Equity, attributable to parent, including:(11,622)(11,074)(10,466)(9,397)(8,908)(7,232)
Common stock121210766
Additional paid in capital38,32038,32038,14237,47837,13036,959
Accumulated deficit(49,954)(49,405)(48,618)(46,882)(46,044)(44,197)
Warrants and rights outstanding7608791,060289412586
Other undisclosed equity, attributable to parent(760)(879)(1,060)(289)(412)(586)
Other undisclosed equity3,1783,1782,515   
Total equity:(8,445)(7,897)(7,950)(9,397)(8,908)(7,232)
TOTAL LIABILITIES AND EQUITY:7461,1931,0491,1781,1212,330

Income Statement (P&L) ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Revenues2,1771,6201,1939272,2882,893
Revenue, net   7,463163  
Cost of revenue(1,766)(1,284)(985)(709)(1,764)(2,221)
Cost of product and service sold   (14)(120)  
Gross profit:411336208218524672
Operating expenses(966)(887)(917)(749)(2,279)(1,346)
Other operating income (expense), net
(Other Expenses)
(21)(441)(1,206)18992459
Other undisclosed operating loss      (459)
Operating loss:(576)(991)(1,915)(343)(1,663)(674)
Interest and debt expense(163)541,181(312)(304)(288)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes2008221,216(107)  
Income (loss) from continuing operations before equity method investments, income taxes:(539)(115)482(761)(1,967)(962)
Other undisclosed loss from continuing operations before income taxes   (2,193)   
Loss from continuing operations before income taxes:(539)(115)(1,710)(761)(1,967)(962)
Income tax expense(5)(5)(14)(41)  
Other undisclosed loss from continuing operations      (171)
Loss from continuing operations:(544)(121)(1,724)(802)(1,967)(1,133)
Loss before gain (loss) on sale of properties:(553)(131)(1,750)(878)(1,967)(1,133)
Loss from discontinued operations(10)(10)(26)(76)  
Other undisclosed net income  5    
Net loss:(553)(125)(1,750)(878)(1,967)(1,133)
Other undisclosed net income attributable to parent5 2,20741120 
Net income (loss) attributable to parent:(548)(125)456(837)(1,848)(1,133)
Preferred stock dividends and other adjustments (662)    
Other undisclosed net loss available to common stockholders, basic  (2,193)   
Net loss available to common stockholders, basic:(548)(787)(1,736)(837)(1,848)(1,133)
Other undisclosed net income available to common stockholders, diluted      
Net loss available to common stockholders, diluted:(548)(787)(1,736)(837)(1,848)(1,133)

Comprehensive Income ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net loss:(553)(125)(1,750)(878)(1,967)(1,133)
Comprehensive loss, net of tax, attributable to parent:(553)(125)(1,750)(878)(1,967)(1,133)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: